Search research articles
Contact Us
Filters
Showing results (41-50 of 203) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2003
Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?
Giovanna Masci, Massimo Magagnoli, Paolo Andrea Zucali, et al.
Expert Opinion on Biological Therapy
|
September 6, 2012
Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients
Massimo Martino, Alberto Bottini, Giovanni Rosti, et al.
European Journal of Haematology
|
January 27, 2007
Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion
Elisabetta Todisco, Luca Castagna, Barbara Sarina, et al.
American Journal of Hematology
|
July 25, 2003
Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution
Massimo Magagnoli, Luca Castagna, Monica Balzarotti, et al.
Life (Basel, Switzerland)
|
March 27, 2025
Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational Study
Stefania Bramanti, Daniela Taurino, Filippo Magri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 4, 2019
Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes
Stefania Bramanti, Valeria Calafiore, Elena Longhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study
Alexia Bertuzzi, Luca Castagna, Andrea Nozza, et al.
Frontiers in Medicine
|
December 23, 2022
The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy
Luca Castagna, Roberto Bono, Stefania Tringali, et al.
European Journal of Haematology
|
January 24, 2019
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide
Jacopo Mariotti, Chiara De Philippis, Stefania Bramanti, et al.
Medical Physics
|
December 11, 2013
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy
Pietro Mancosu, Piera Navarria, Luca Castagna, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 203) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2003
Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?
Giovanna Masci, Massimo Magagnoli, Paolo Andrea Zucali, et al.
Expert Opinion on Biological Therapy
|
September 6, 2012
Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients
Massimo Martino, Alberto Bottini, Giovanni Rosti, et al.
European Journal of Haematology
|
January 27, 2007
Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion
Elisabetta Todisco, Luca Castagna, Barbara Sarina, et al.
American Journal of Hematology
|
July 25, 2003
Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution
Massimo Magagnoli, Luca Castagna, Monica Balzarotti, et al.
Life (Basel, Switzerland)
|
March 27, 2025
Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational Study
Stefania Bramanti, Daniela Taurino, Filippo Magri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 4, 2019
Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes
Stefania Bramanti, Valeria Calafiore, Elena Longhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study
Alexia Bertuzzi, Luca Castagna, Andrea Nozza, et al.
Frontiers in Medicine
|
December 23, 2022
The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy
Luca Castagna, Roberto Bono, Stefania Tringali, et al.
European Journal of Haematology
|
January 24, 2019
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide
Jacopo Mariotti, Chiara De Philippis, Stefania Bramanti, et al.
Medical Physics
|
December 11, 2013
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy
Pietro Mancosu, Piera Navarria, Luca Castagna, et al.
Page
of 21